Analyst firms · Needham · EFX
Needham EFX price target and rating history
Equifax Inc. (EFX) · Finance
Needham rates Equifax Inc. (EFX) Buy with a $305 price target, as of its latest action on Jan 4, 2024. It has published 4 rating actions on EFX since July 2021, including 0 upgrades and 0 downgrades. Across 6 firms with a EFX price target in the last 12 months, the median target is $228.50.
- Current rating
- Buy
- Price target
- $305
- Median target, all firms
- $228.50
- Actions on EFX
- 4
Needham price target on EFX
Every Needham rating on EFX
- Jan 4, 2024
- Nov 12, 2021
- Oct 14, 2021
- Jul 22, 2021
How other firms rate EFX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Sector Perform | $189 | Oct 26, 2026 |
| Argus Research | Buy | $200 | Oct 22, 2026 |
| Oppenheimer | Perform | Oct 16, 2026 | |
| BNP Paribas Exane | Outperform | $245 | Sep 8, 2026 |
| Rothschild & Co Redburn | Buy | $235 | Aug 21, 2026 |
| Mizuho | Outperform | $222 | Apr 16, 2026 |
| BofA Securities | Buy | $250 | Feb 17, 2026 |
Questions about Needham and EFX
- What is Needham's price target for EFX?
- Needham's latest stated price target for Equifax Inc. (EFX) is $305, from its action on Jan 4, 2024.
- What is Needham's rating on EFX?
- Needham rates EFX Buy, a bullish rating, as of Jan 4, 2024.
- When did Needham last change its view on EFX?
- On Jan 4, 2024, Needham raises its price target to $305 from $230, keeps Buy.
- How does Needham's EFX target compare with other analysts?
- Across 6 firms with a EFX price target in the last 12 months, the median target is $228.50.
More EFX rating histories
- RBC Capital Markets7
- Argus Research3
- Oppenheimer3
- BNP Paribas Exane6
- BofA Securities6
- Morgan Stanley8
- Wells Fargo3
- Evercore ISI3
All Needham ratingsEFX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.